| News and Events |
||
Home |
GE HEALTHCARE DEBUTS ALCYONE TECHNOLOGY; NEXT GENERATION IN NUCLEAR CARDIOLOGY | |
News and Events |
Harnessing Four Leading Nuclear-Imaging Innovations, Alcyone Technology Has Ability to Reduce Scan Time, While Increasing Diagnostic Confidence and Efficiency | |
| For More Information Contact
Kathleen N DeRitter kathleen.n.deritter@ge.com GE Healthcare 414-721-2428 |
||
| March 25, 2009 | ||
|
|
||
GE Healthcare, a unit of General Electric Company (NYSE:GE), announced the launch of Alcyone Technology, a nuclear cardiology platform combining cadmium zinc telluride (CZT) detectors, focused pin-hole collimation, 3D reconstruction, and stationary data acquisition, to improve workflow, dose management, and overall image quality. “We haven’t seen a revolution of this magnitude in Nuclear Cardiology in more than 50 years,” said Nathan Hermony, general manager of GE Healthcare’s Nuclear Imaging business. “With this technology, we have the opportunity to raise the industry standard of diagnosis and workflow.” The new Alcyone technology will be available on both the Discovery NM 530c and the Discovery NM/CT 570c. Alcyone’s heightened sensitivity and zero equipment motion improves both image quality and energy resolution, enabling the potential for new clinical applications including 3D dynamic acquisitions and simultaneous dual isotope imaging. Building a growth framework for nuclear cardiology departments to evolve with changing patient needs, GE Healthcare also provides a practical upgrade pathway from Ventri, the dedicated conventional nuclear cardiology camera. With the launch of Alycone technology, clinicians now have the option of upgradeability to the Discovery NM530c and Discovery NM/CT 570c systems. GE Healthcare’s Alcyone technology will be showcased with the Discovery NM 530c on display at the American College of Cardiology 58th Annual Scientific Session in Orlando, FL March 29-31, 2009 at booth 2328.
|
||
| ABOUT GE HEALTHCARE | |
GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our broad expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, performance improvement and performance solutions services help our customers to deliver better care to more people around the world at a lower cost. In addition, we partner with healthcare leaders, striving to leverage the global policy change necessary to implement a successful shift to sustainable healthcare systems. Our "healthymagination" vision for the future invites the world to join us on our journey as we continuously develop innovations focused on reducing costs, increasing access and improving quality and efficiency around the world. Headquartered in the United Kingdom, GE Healthcare is a $17 billion unit of General Electric Company (NYSE: GE). Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at www.gehealthcare.com |